Business Context and Reporting Period
This Form 8-K was filed by Shuttle Pharmaceuticals Holdings, Inc. on January 26, 2023. The Company is a Delaware corporation headquartered in Rockville, Maryland, and its common stock trades on The Nasdaq Stock Market under the symbol "SHPH". The report is classified as an "Other Event" (Item 8.01) and does not cover a specific financial reporting period.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a corporate event and does not contain financial statements or performance data.
Material Changes
There are no material changes to financial conditions or operations reported in this filing. The document solely announces a scheduled investor relations event.
Guidance, Outlook, and Management Commentary
The Company announced that its Chief Executive Officer, Dr. Anatoly Dritschilo, will present and host one-on-one meetings with investors at the Lytham Partners Investor Select Conference. The event is scheduled to take place virtually on January 31, 2023. No specific financial guidance or risk factors were disclosed in this report.
Key Facts for Investor Verification
- Event Date: January 31, 2023.
- Event Type: Lytham Partners Investor Select Conference (Virtual).
- Key Participant: Dr. Anatoly Dritschilo, Chief Executive Officer.
- Activity: Presentation and one-on-one investor meetings.
- Financial Data: None provided in this filing; investors should refer to the Company's most recent 10-K or 10-Q for financial metrics.